Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions (Q34616707)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mehrul Hasnain

1

1 reference

Europe PubMed Central

3 August 2017

W Victor R Vieweg

2

1 reference

Europe PubMed Central

3 August 2017

Sonja K Fredrickson

3

1 reference

Europe PubMed Central

3 August 2017

publication date

1 March 2010

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

24

1 reference

Europe PubMed Central

3 August 2017

3

1 reference

Europe PubMed Central

3 August 2017

193-206

1 reference

Europe PubMed Central

3 August 2017

https://scigraph.springernature.com/pub.10.2165/11530130-000000000-00000

0 references

An update on the Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.2165%2F11530130-000000000-00000

21 January 2018

The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes

1 reference

https://api.crossref.org/works/10.2165%2F11530130-000000000-00000

21 January 2018

Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.2165%2F11530130-000000000-00000

21 January 2018

Meta-analysis: metformin treatment in persons at risk for diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin: a review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin as treatment for overweight and obese adults: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression from newly acquired impaired fasting glusose to type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 5-HT2C receptor and antipsychoticinduced weight gain - mechanisms and genetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin and polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schizophrenia, obesity, and antipsychotic medications: what can we do?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body weight gain induced by antipsychotic drugs: mechanisms and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin before and during pregnancy and lactation in polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schizophrenia, antipsychotics and diabetes: Genetic aspects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotics and diabetes: an age-related association

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal cutoff values for overweight: using body mass index to predict incidence of hypertension in 18- to 65-year-old Chinese adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes As

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overweight and obesity in the United States: prevalence and trends, 1960-1994

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BMI and waist circumference in predicting cardiovascular risk factor clustering in Chinese adolescents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cut-off values for waist circumference in rural Iraqi adults for the diagnosis of metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ethnic differences in the association between body mass index and hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and classification of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and treatment of prediabetes to prevent progression to type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin for weight loss in pediatric patients taking psychotropic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical study of the association of antipsychotics with hyperlipidemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic profiling of plasma from discordant schizophrenia twins: correlation between lipid signals and global functioning in female schizophrenia patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin in obesity associated with antipsychotic drug administration: a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The utility of fasting glucose for detection of prediabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drugs and diabetes--an application of the Austin Bradford Hill criteria.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Weight change with atypical antipsychotics in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adipose tissue, inflammation, and cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological management of atypical antipsychotic-induced weight gain.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacology and safety of paliperidone extended-release in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolic effects of antipsychotic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The link between abdominal obesity and the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schizophrenia and increased risks of cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20155995

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/11530130-000000000-00000

1 reference

Europe PubMed Central

3 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34616707&oldid=1977388623"